Thank you, Mr. Chair.
Welcome, and thank you for your presentations.
We are investing significant money in research and development, as you know. My concern is, are other patients in other countries getting increased access to our innovative therapies and discoveries, more so than Canadians?
We did hear some reference to that and some concern that was raised. I know you also referenced that in your remarks. In other words, we're making the discoveries, and others are having increased access to those innovative therapies, more so than Canadians. That was the concern that had been raised.